Published in Cancer Res on August 15, 1992
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J Immunother (2013) 4.80
Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn. Adv Immunol (2009) 1.42
Anti-GD2 antibody therapy for GD2-expressing tumors. Curr Cancer Drug Targets (2010) 1.28
Phage-display library selection of high-affinity human single-chain antibodies to tumor-associated carbohydrate antigens sialyl Lewisx and Lewisx. Proc Natl Acad Sci U S A (1999) 1.24
Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells. Clin Cancer Res (2009) 1.15
Intratumoral immunocytokine treatment results in enhanced antitumor effects. Cancer Immunol Immunother (2008) 1.13
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma. J Clin Oncol (2014) 1.09
Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma. Cancer (2013) 1.02
Anti-GD2 Strategy in the Treatment of Neuroblastoma. Drugs Future (2010) 1.00
The inducible caspase-9 suicide gene system as a "safety switch" to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells. Front Pharmacol (2014) 0.95
The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma. Expert Opin Investig Drugs (2009) 0.92
A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity. PLoS One (2011) 0.91
Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model. J Transl Med (2012) 0.87
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice. Cancer Immunol Immunother (2008) 0.87
Immune therapies for neuroblastoma. Cancer Biol Ther (2009) 0.85
Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics. Front Immunol (2015) 0.84
Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues. J Clin Immunol (2000) 0.80
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity. Semin Oncol (2015) 0.79
Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy. Immunotherapy (2016) 0.77
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody. Cancer (2013) 0.77
Comparison of pain outcomes between two anti-GD2 antibodies in patients with neuroblastoma. Pediatr Blood Cancer (2014) 0.76
Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia. PLoS One (2014) 0.75
Ligands Binding to Cell Surface Ganglioside GD2 Cause Src-Dependent Activation of N-Methyl-D-Aspartate Receptor Signaling and Changes in Cellular Morphology. PLoS One (2015) 0.75
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem (1983) 9.32
HIV infection is blocked in vitro by recombinant soluble CD4. Nature (1988) 4.58
Differential localization of two myosins within nematode thick filaments. Cell (1983) 3.84
Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med (1999) 3.54
Measuring the diaspora for virus-specific CD8+ T cells. Proc Natl Acad Sci U S A (2001) 3.51
High-performance lithium-ion anodes using a hierarchical bottom-up approach. Nat Mater (2010) 3.25
Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys (1994) 2.77
Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region. Oncogene (2010) 2.73
Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature (1984) 2.66
Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site. J Biol Chem (1985) 2.64
Interlaboratory comparison of ultrasonic backscatter, attenuation, and speed measurements. J Ultrasound Med (1999) 2.47
Transforming growth factor-beta controls receptor levels for epidermal growth factor in NRK fibroblasts. Cell (1984) 2.30
Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest (1991) 2.28
Do minutes count? Consultation lengths in general practice. J Health Serv Res Policy (1998) 2.23
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1993) 2.22
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci U S A (1989) 2.15
Hukou and non-hukou migrations in China: comparisons and contrasts. Int J Popul Geogr (2000) 2.06
Rates of ligand binding to periplasmic proteins involved in bacterial transport and chemotaxis. J Biol Chem (1983) 2.06
Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J Biol Chem (1999) 2.05
Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer. J Nucl Med (1997) 2.05
Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys (1994) 2.01
Supplemental oxygen does not reduce myocardial ischemia in premedicated patients with critical coronary artery disease. Anesth Analg (1993) 2.00
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1994) 1.96
Association of influenza virus matrix protein with ribonucleoproteins. J Virol (1999) 1.95
Does a centralized radiotherapy system provide adequate access to care? J Clin Oncol (1997) 1.90
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol (2001) 1.87
Patients' awareness of stroke signs, symptoms, and risk factors. Stroke (1997) 1.85
Immunological identification of the genes encoding the four myosin heavy chain isoforms of Caenorhabditis elegans. Proc Natl Acad Sci U S A (1986) 1.84
Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J Immunol (1999) 1.81
Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem (2000) 1.80
The Groucho-like transcription factor UNC-37 functions with the neural specificity gene unc-4 to govern motor neuron identity in C. elegans. Development (1997) 1.77
Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood (1997) 1.77
Acute stroke: delays to presentation and emergency department evaluation. Ann Emerg Med (1999) 1.77
Myosin and paramyosin are organized about a newly identified core structure. J Cell Biol (1985) 1.76
Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci U S A (1992) 1.72
Active conformation of the globin genes in uninduced and induced mouse erythroleukemia cells. Cell (1978) 1.64
Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity. Pediatr Blood Cancer (2004) 1.61
Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model. Am J Transplant (2012) 1.61
Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J Pathol (2001) 1.61
Use of chlorotoxin for targeting of primary brain tumors. Cancer Res (1998) 1.59
Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve (1988) 1.57
Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells. Oncogene (2012) 1.55
Effects of erythorbic acid on vitamin C metabolism in young women. Am J Clin Nutr (1996) 1.55
Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques. Nature (1989) 1.55
Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with respiratory syncytial virus. Role in viral-induced interferon regulatory factor activation. J Biol Chem (2001) 1.53
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2010) 1.53
Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest (1989) 1.53
Blood volume redistribution during cross-clamping of the descending aorta. Anesth Analg (1994) 1.52
Dynamic dead space in face masks used with noninvasive ventilators: a lung model study. Eur Respir J (2004) 1.51
Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall. Circulation (2001) 1.50
UNC-4/UNC-37-dependent repression of motor neuron-specific genes controls synaptic choice in Caenorhabditis elegans. Genes Dev (1999) 1.50
Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer. J Nucl Med (1992) 1.49
Results of conservative management of cervical intraepithelial neoplasia. Obstet Gynecol (1992) 1.49
Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation. Cancer Biother Radiopharm (1999) 1.49
Effects of UDP-glucose addition on the synthesis of mannosyl lipid-linked oligosaccharides by cell-free fibroblast preparations. J Biol Chem (1977) 1.49
Cadmium-binding component in Escherichia coli during accommodation to low levels of this ion. Appl Environ Microbiol (1981) 1.49
French without tears? Foreign accent syndrome. J R Soc Med (2004) 1.47
Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol (1991) 1.47
Identification of myosin heavy chain in Saccharomyces cerevisiae. Nature (1985) 1.47
Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids (1996) 1.44
Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity (1997) 1.44
Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol (2000) 1.44
The winged helix/forkhead transcription factor Foxq1 regulates differentiation of hair in satin mice. Genesis (2001) 1.44
Activation of a frizzled-2/beta-adrenergic receptor chimera promotes Wnt signaling and differentiation of mouse F9 teratocarcinoma cells via Galphao and Galphat. Proc Natl Acad Sci U S A (1999) 1.42
Intensity-modulated radiotherapy in the treatment of breast cancer. Clin Oncol (R Coll Radiol) (2012) 1.42
Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. Patient Educ Couns (2001) 1.42
The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter. Mol Pharmacol (1998) 1.41
Comparison of a 6-hour and 9-hour protocol for evaluation of moderate-to-low risk chest pain patients in an emergency department diagnostic unit. Singapore Med J (2001) 1.41
Measurement of cardiac troponin T is an effective method for predicting complications among emergency department patients with chest pain. Ann Emerg Med (1998) 1.41
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Paraneoplastic opsoclonus-myoclonus. Association with medullary thyroid carcinoma and review of the literature. Arch Neurol (1986) 1.40
Genomic DNA sequence for human C-reactive protein. J Biol Chem (1985) 1.39
Induction of telomerase activity in fibroblasts from bleomycin-injured lungs. Am J Respir Cell Mol Biol (2000) 1.39
Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue. Obesity (Silver Spring) (2009) 1.39
The distribution of refractory periods influences the dynamics of ventricular fibrillation. Circ Res (2001) 1.38
Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry (1991) 1.38
Expression of human endogenous retrovirus k envelope transcripts in human breast cancer. Clin Cancer Res (2001) 1.38
Purification and properties of a plasmid-encoded 2,4-dichlorophenol hydroxylase. FEBS Lett (1984) 1.38
Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol (2006) 1.37
Changes in the use of radiotherapy in Ontario 1984-1995. Int J Radiat Oncol Biol Phys (1999) 1.36
Localization and enhanced current density of the Kv4.2 potassium channel by interaction with the actin-binding protein filamin. J Neurosci (2000) 1.35
Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc Brain Metab Rev (1994) 1.35
Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects. Clin Pharmacol Ther (1995) 1.34
Aberrant metal binding by prion protein in human prion disease. J Neurochem (2001) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
HIV-1 capsid protein forms spherical (immature-like) and tubular (mature-like) particles in vitro: structure switching by pH-induced conformational changes. Biophys J (2001) 1.32
Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides. J Biol Chem (2001) 1.32
The aldolase-binding site of the human erythrocyte membrane is at the NH2 terminus of band 3. J Biol Chem (1981) 1.31
Metastatic cystosarcoma phyllodes: a case report and review of the literature. J Surg Oncol (1972) 1.30
Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities. J Neurochem (2001) 1.30
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Ribosomes in thiostrepton-resistant mutants of Bacillus megaterium lacking a single 50 S subunit protein. J Mol Biol (1979) 1.29
Minimally invasive total hip arthroplasty: a systematic review. Int Orthop (2009) 1.28
Segmentation of touching cell nuclei using gradient flow tracking. J Microsc (2008) 1.28